What Is Burning Rock Biotech Limited (BNR) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Burning Rock Biotech Limited's intrinsic value is estimated at a composite fair value of $14.91. While the stock appears modestly undervalued at $9.60 (implied upside of +55.3%), our analysis suggests a thinner margin of safety across 8 of 12 bullish models. Notably, FTNN sees the most upside at +286.3% (fair value: $37.08), while ML-RIV is the most conservative at -53.1% ($4.50). The spread between these extremes — +339.4% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About BNR?
12 of 13 models are currently active for BNR. Of these, 8 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates BNR's intrinsic value at $6.14, implying -36.1% downside from the current price. See which stocks rank higher →
How Does BNR Rank in Services-Medical Laboratories?
Among 24 Services-Medical Laboratories stocks, BNR ranks #13 by Quality of Company score. CirclFi's QOC score of 6.2/10 evaluates 32 fundamental signals. A score of 6.2 indicates above-average quality.
Burning Rock Biotech Limited operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is BNR a Value Trap?
CirclFi's Value Trap algorithm assigns BNR a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Burning Rock Biotech Limited. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Burning Rock Biotech Limited scores 6.2 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +339.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BNR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across BNR's 12 active models, average confidence is 26%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad